Scarica l'app Stockscreener
5.36
3.68%
-0.205
Kyntra Bio Inc Azioni (KYNB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
139.43%
-1.474
|
3.738 | 1.277 | 1.076 | 1.348 |
| Cost Of Revenue |
99.95%
0.002
|
4.106 | 0.278 | -0.058 | 0.085 |
Selling, General, and Administrative
|
58.07%
9.266
|
5.862 | 7.25 | 5.295 | 7.057 |
| Interest Income/Expense |
2.43%
2.368
|
2.427 | 2.413 | 2.083 | 2.009 |
| Costs And Expenses |
8.29%
16.10
|
17.56 | 14.79 | 6.487 | 13.40 |
| Operating Income/Loss |
27.18%
-17.57
|
-13.82 | -13.51 | -5.411 | -12.05 |
| Nonoperating Income/Loss |
12.40%
0.975
|
1.113 | 1.315 | 0.931 | 0.286 |
| Income/Loss From Continuing Operations Before Tax |
179.12%
11.97
|
-15.13 | -14.61 | -13.15 | -13.78 |
| Income Tax Expense/Benefit |
-0.001
|
- | - | - | -0.092 |
| Income/Loss From Continuing Operations After Tax |
179.13%
11.97
|
-15.13 | -14.61 | -13.15 | -13.68 |
| Income/Loss From Discontinued Operations, Net Of Tax |
100.00%
-
|
-0.066 | 0.39 | 213.78 | 6.08 |
| Net Income/Loss |
178.79%
11.97
|
-15.20 | -14.22 | 200.64 | -7.603 |
| Basic Average Shares |
0.02%
4.048
|
4.047 | - | 4.044 | 4.042 |
| Diluted Average Shares |
0.02%
4.048
|
4.047 | - | 4.044 | 4.042 |
| Basic Earnings Per Share |
178.72%
2.96
|
-3.76 | - | 49.61 | -1.88 |
| Diluted Earnings Per Share |
178.72%
2.96
|
-3.76 | - | 49.61 | -1.88 |
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):